Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DepoTXA for postsurgical bleeding in TKA
NCT02922582Phase 2Terminated
- Sponsor
- Pacira BioSciences
- Start
- Oct 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of tranexamic acid in postoperative hemorrhage (4 arms), sponsored by Pacira BioSciences. Primary endpoints: Area Under the Plasma Concentration-versus-time Curve From Time 0 Extrapolated to Infinity up to 96 hours, Area Under the Plasma Concentration-versus-time Curve From Time 0 to the Last Collection Time up to 96 hours and 4 more. Started Oct 2016; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT02922582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922582.